FUSED HETEROCYCLIC SUCCINIMIDECOMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION

WIPO Patent Application WO2003062241

A8

Fused cyclic compounds method of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

SALVATI MARK E (US)
BALOG JAMES AARON (US)
PICKERING DACIA A (US)
GIESE SOREN (US)
FURA ABERRA (US)
LI WENYING (US)
PATEL RAMESH N (US)
HANSON RONALD L (US)
MITT TOOMAS (US)
ROBERGE JACQUES (US)
CORTE JAMES R (US)
SPERGEL STEVEN H (US)
RAMPULLA RICHARD A (US)
MISRA RAJ (US)
XIAO HAI-YUN (US)

PCT/US2002/040598

October 21, 2004

December 18, 2002

Click for automatic bibliography generation  

BRISTOL MYERS SQUIBB CO (US)
SALVATI MARK E (US)
BALOG JAMES AARON (US)
PICKERING DACIA A (US)
GIESE SOREN (US)
FURA ABERRA (US)
LI WENYING (US)
PATEL RAMESH N (US)
HANSON RONALD L (US)
MITT TOOMAS (US)
ROBERGE JACQUES (US)
CORTE JAMES R (US)
SPERGEL STEVEN H (US)
RAMPULLA RICHARD A (US)
MISRA RAJ (US)
XIAO HAI-YUN (US)

A61K31/40; A61K31/407; C07D487/18; A61K31/4155; A61K31/416; A61K31/4178; A61K31/4184; A61K31/4192; A61K31/4196; A61K31/422; A61K31/423; A61K31/4245; A61K31/427; A61K31/428; A61K31/433; A61K31/437; A61K31/439; A61K31/4439; A61K31/454; A61K31/4709; A61K31/4725; A61K31/498; A61K31/506; A61K31/52; A61K31/5377; A61K31/7052; A61P1/14; A61P3/06; A61P3/10; A61P5/26; A61P5/28; A61P5/32; A61P5/46; A61P7/00; A61P9/04; A61P13/08; A61P15/00; A61P15/02; A61P15/04; A61P15/08; A61P15/18; A61P17/08; A61P17/10; A61P17/14; A61P19/10; A61P21/02; A61P25/18; A61P25/28; A61P25/30; A61P29/00; A61P35/00; A61P37/02; C07D471/18; C07D491/00; C07D491/18; C07D491/22; C07D495/18; C07D519/00; C07H17/00; (IPC1-7): C07D491/00; A61K31/40

View/Download PDF      PDF Help

Previous Patent: PTERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF

Next Patent: 2−THIA−1,6,8−TRIAZA−NAPHTALENE−2,2−DIOXIDES AS CDK INHIBITORS